Essential medicines and health products

Substandard and Falsified (SF) Medical Products

The existence of substandard and falsified (SF) medical products is an unacceptable risk to public health. They affect every region of the world, and medicines from all major therapeutic categories have been reported, including vaccines and diagnostics. They harm patients and undermine confidence in medical products, healthcare professionals and health systems. WHO is working with stakeholders to minimize the risks from SF medical products by collecting data and transferring knowledge and good practices to countries.

News and Announcements

We have updated the webpage on ‘Technology to tackle SF Medical Products’ with the first of USP’s Technology Review reports. This webpage will be updated as additional reviews are published.

Recent and Forthcoming Events

  • 8-12 January 2018

    Myanmar Health Research Congress

    Yangon, Myanmar

  • 30 November - 1 December, 2017

    6th Member State Mechanism Meeting

    Geneva, Switzerland

Contact us

SF Medical Products Group
Essential Medicines and Health Products
World Health Organization
20 avenue Appia
1211 Geneva 27